In vitro Opposition binding studies confirmed that MAM-2201 and AM-2201 have nanomolar affinity for equally CD-1 murine and human CB1 and CB2 receptors, with choice to the CB1 receptor. In agreement with the in vitro binding facts, in vivo scientific studies confirmed that MAM-2201 induces visual, acoustic, and tactile impairments https://garryr494ynb6.verybigblog.com/profile